BURLINGTON, Mass., March 26, 2014 /PRNewswire/ -- Decision Resources Group conducts extensive primary and secondary market research on the biosimilars space globally and within Europe and will be sharing key insights and analysis in a content-rich, one-day seminar.

The Competitive Landscape Seminar: Biosimilars will be held on April 9, 2014, at the Sofitel London Heathrow. Seminar content is intended for biopharmaceutical professionals involved in market research, business development, competitive intelligence, market access and biologics or biosimilars product teams.

Presentation topics include:

  • Impact of Stakeholder Perceptions on Biosimilars' Commercial Success
  • Competitive Landscape of the Global Biosimilars Sector
  • Biosimilars versus Brands for Rheumatoid Arthritis: EU5 Payers and Prescribers Place Their Bets
  • Maximize the Biosimilar Opportunity in Brazil and Mexico: Payer and Rheumatologist Perspectives
  • Avastin: Trials, Tribulations, Threats

The agenda also includes a panel discussion that will address key issues around biosimilars including:

  • Automatic substitution
  • Indication extrapolation
  • Clinical trial design

Confirmed panelists include: Professor Yannick Allanore, Paris Descartes University, Cochin Hospital; Professor Andrea Gallamini, A. Lacassagne Cancer Center, Nice University; Dr. Anthony Grosso, UCL Hospitals; Professor David Isenberg, University College London Medical School.

For more information and to register, please visit:

Media Contact
Media interested in further information or in attending the seminar should contact Lisa Osgood at losgood@dresourcesgroup.com or +1 781.993.2606.

About Decision Resources Group
Decision Resources Group offers best-in-class, high-value information and insights on critical issues within the healthcare industry. Clients rely on this analysis and data to make informed decisions. Find out more at www.DecisionResourcesGroup.com.

All company, brand, or product names contained in this document may be trademarks or
registered trademarks of their respective holders.

For more information, contact:

Decision Resources Group
Christopher Comfort

Logo - http://photos.prnewswire.com/prnh/20130103/MM36768LOGO

SOURCE Decision Resources Group

Breast Cancer Treatment Will Become More Dynamic as Newer Targeted Agents and Regimens Involving Combination Targeted Therapies Launch Over the Next Few Years

View Now